CMS Extends Medicare’s Short-Term Bridge Program for GLP-1 Obesity Drug Coverage
(By Juliette Cubanski for The Kaiser Family Foundation published April 23, 2026) The Centers for Medicare & Medicaid Services (CMS)
Read More
GLP-1
Ozempic predecessor may slow Parkinson’s progression, new study shows
By Erica Carbajal for Becker’s Hospital Review on April 4, 2024 A small study has found lixisenatide, a GLP-1 made
Read More